Financhill
Back

Cognizant Technology Solutions Vs. Akero Therapeutics Industry Stock Comparison

Sell
45

CTSH
Cognizant Technology Solutions

Last Price:
$78.94
Seasonality Move:
6.11%
Buy
64

AKRO
Akero Therapeutics

Last Price:
$55.60
Seasonality Move:
13.24%
Sell
45
Cognizant Technology Solutions (CTSH) is a Sell

Is Cognizant Technology Solutions a Buy, Sell or Hold?

  • The current Cognizant Technology Solutions [CTSH] share price is $78.95. The Score for CTSH is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • CTSH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Akero Therapeutics (AKRO) is a Buy

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $55.62. The Score for AKRO is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • AKRO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CTSH Stock Price Chart

What is Cognizant Technology Solutions's stock price today?

  • The Cognizant Technology Solutions share price today is $78.95
    The current trend is moderately bearish and CTSH is experiencing selling pressure, which indicates risk of future bearish movement.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $55.62
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.

CTSH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.43 Buy
Relative Strength Index (14 RSI): 47.12 Sell
Chaikin Money Flow: -1698857 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (79.68 - 81.22) Sell
Bollinger Bands (100): (74.01 - 84.47) Sell

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.22 Buy
Relative Strength Index (14 RSI): 69.42 Buy
Chaikin Money Flow: 1967952 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.81 - 53.51) Buy
Bollinger Bands (100): (37.5 - 51.86) Buy

CTSH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 80.12 Sell
20-day SMA: 80.36 Sell
50-day SMA: 76.39 Buy
200-day SMA: 78.43 Buy
8-day EMA: 80.11 Sell
20-day EMA: 79.63 Sell
50-day EMA: 71.27 Buy
200-day EMA: 34.74 Buy

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.07 Buy
20-day SMA: 49.61 Buy
50-day SMA: 43.75 Buy
200-day SMA: 36.79 Buy
8-day EMA: 53.49 Buy
20-day EMA: 50.33 Buy
50-day EMA: 46.33 Buy
200-day EMA: 38.56 Buy

Cognizant Technology Solutions Earnings Growth & CTSH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.07 per share, an increase this year of $0.41 per share, and an increase next year of $0.34 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.

Cognizant Technology Solutions Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):